Chutes & Ladders—Sage CMO steps down amid pipeline struggles.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 3/7/2025, pN.PAG-N.PAG. 1p.

Pfizer adds J&J, BMS vet James List to its executive roster as new chief internal medicine officer.

Authors: Becker, Zoey (AUTHOR)

Source: FierceBiotech. 3/7/2025, pN.PAG-N.PAG. 1p.

Sanofi bounces midstage ILT2 asset back to Biond Biologics after $125M bet.

Authors: Becker, Zoey (AUTHOR)

Source: FierceBiotech. 3/3/2025, pN.PAG-N.PAG. 1p.

Chutes & Ladders—Private equity firms take over bluebird's nest.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 2/28/2025, pN.PAG-N.PAG. 1p.

Subject Terms: *Private equity, *Chief executive officers, *Business enterprises, Scholars, Life sciences

Chutes & Ladders—NIH leaders join health agency exodus.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 2/21/2025, pN.PAG-N.PAG. 1p.

Subject Terms: Oncology, Teams

Chutes & Ladders—Neumora overhauls C-suite after phase 3 flop.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 2/14/2025, pN.PAG-N.PAG. 1p.

Subject Terms: *Chief executive officers, Explorers, Drugs

Geographic Terms: Lycia

Chutes & Ladders—J&J vet jumps to Affinia.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 2/7/2025, pN.PAG-N.PAG. 1p.

Subject Terms: *Dismissal of employees, Biopharmaceutics, Oncology

Company/Entity: United States. Food & Drug Administration , Pfizer Inc. 001326495 PFE

Chutes & Ladders—Takeda taps Julie Kim as new CEO.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 1/31/2025, pN.PAG-N.PAG. 1p.

Subject Terms: *Senior leadership teams, *Chief executive officers, Life sciences, Scholars

Chutes & Ladders—Flagship vet plants CEO roots at Pharming.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 1/24/2025, pN.PAG-N.PAG. 1p.

Subject Terms: Plant roots

Eli Lilly, Andreessen Horowitz link up on $500M biotech venture fund.

Authors: Becker, Zoey (AUTHOR)

Source: FierceBiotech. 1/10/2025, pN.PAG-N.PAG. 1p.

Subject Terms: *Venture capital companies, *Venture capital, *Artificial intelligence, Ecosystems

Company/Entity: Eli Lilly & Co. LLY

Chutes & Ladders—Amylyx preps for GLP-1 launch with new CCO.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 1/10/2025, pN.PAG-N.PAG. 1p.

Subject Terms: *Biotechnology, *Chief executive officers, Drugs, Oncology

Chutes & Ladders—Vincerx acquisition leads to C-suite shake-up.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 1/3/2025, pN.PAG-N.PAG. 1p.

Subject Terms: *Biotechnology, Lexicon, Drugs

Chutes & Ladders—FDA's principal deputy to depart agency.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 12/20/2024, pN.PAG-N.PAG. 1p.

Subject Terms: *Leadership, *Executives, Research evaluation, Jazz, Drugs

Merck's HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies.

Authors: Becker, Zoey (AUTHOR)

Source: FierceBiotech. 12/19/2024, pN.PAG-N.PAG. 1p.

Subject Terms: HIV

Company/Entity: Merck KGaA

Chutes & Ladders—AI firm Xaira powers up C-suite with pharma vet.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 12/13/2024, pN.PAG-N.PAG. 1p.

Subject Terms: *Biotechnology industries, *Artificial intelligence, *Leadership

Company/Entity: Merck KGaA

Chutes & Ladders—Stanford economist is Trump's NIH pick.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 12/6/2024, pN.PAG-N.PAG. 1p.

Subject Terms: *Chief executive officers, *Universities & colleges, Drugs, Life sciences

Novo Holdings-backed Antag raises $84M series A to send complementary obesity candidate to the clinic.

Authors: Becker, Zoey (AUTHOR)

Source: FierceBiotech. 12/4/2024, pN.PAG-N.PAG. 1p.

Subject Terms: *Venture capital, Obesity, Drugs, Teams

Janux's T-cell engager makes waves, again, with 'best-in-class' data drop: analyst.

Authors: Becker, Zoey (AUTHOR)

Source: FierceBiotech. 12/3/2024, pN.PAG-N.PAG. 1p.

Subject Terms: Therapeutics, Prostate cancer, T cells, Cancer treatment

Merus' head and neck cancer candidate bolsters 'best-in-disease' profile with new data drop: analyst.

Authors: Becker, Zoey (AUTHOR)

Source: FierceBiotech. 12/2/2024, pN.PAG-N.PAG. 1p.

Subject Terms: Head & neck cancer, Squamous cell carcinoma, Neuregulins, Clinical trials, Cancer research

Chutes & Ladders—Pfizer replaces retiring CSO with cancer chief.

Authors: Incorvaia, Darren (AUTHOR), Becker, Zoey (AUTHOR)

Source: FierceBiotech. 11/22/2024, pN.PAG-N.PAG. 1p.

Subject Terms: *Biotechnology, Biopharmaceutics, Research evaluation, Natural satellites, Drugs